| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/02/2022 | 21.35% | Wells Fargo | → $49 | Initiates Coverage On | → Overweight |
| 07/15/2022 | 16.39% | Keybanc | → $47 | Initiates Coverage On | → Overweight |
| 03/09/2022 | 4.01% | B of A Securities | $48 → $42 | Maintains | Buy |
| 03/09/2022 | -25.71% | SVB Leerink | $25 → $30 | Maintains | Outperform |
| 11/05/2021 | 36.21% | SVB Leerink | $46 → $55 | Maintains | Outperform |
| 10/11/2021 | 18.87% | B of A Securities | → $48 | Initiates Coverage On | → Buy |
| 10/11/2021 | 23.82% | Cowen & Co. | → $50 | Initiates Coverage On | → Outperform |
| 10/11/2021 | 11.44% | Guggenheim | → $45 | Initiates Coverage On | → Buy |
| 10/11/2021 | 13.92% | SVB Leerink | → $46 | Initiates Coverage On | → Outperform |
| 10/11/2021 | -8.37% | Goldman Sachs | → $37 | Initiates Coverage On | → Neutral |
PROCEPT BioRobotics Questions & Answers
The latest price target for PROCEPT BioRobotics (NASDAQ: PRCT) was reported by Wells Fargo on September 2, 2022. The analyst firm set a price target for $49.00 expecting PRCT to rise to within 12 months (a possible 21.35% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for PROCEPT BioRobotics (NASDAQ: PRCT) was provided by Wells Fargo, and PROCEPT BioRobotics initiated their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PROCEPT BioRobotics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PROCEPT BioRobotics was filed on September 2, 2022 so you should expect the next rating to be made available sometime around September 2, 2023.
While ratings are subjective and will change, the latest PROCEPT BioRobotics (PRCT) rating was a initiated with a price target of $0.00 to $49.00. The current price PROCEPT BioRobotics (PRCT) is trading at is $40.38, which is within the analyst's predicted range.